oaioai:kar.kent.ac.uk:12305

Assessment of health economics in Alzheimer's disease (AHEAD): treatment with galantamine in the UK

Authors
Publication date
1 January 2003
Publisher
OHN WILEY & SONS LTD
Doi

    Abstract

    Objective To assess the long-term health and economic impact of treating mild to moderate Alzheimer's disease (AD) with galantamine (16 mg or 24 mg per day) compared to no cholinesterase therapy in the U

    Similar works

    Full text

    thumbnail-image

    Kent Academic Repository

    redirect
    oaioai:kar.kent.ac.uk:12305
    Last time updated on 23/02/2012

    This paper was published in Kent Academic Repository.

    Having an issue?

    Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.